Clinical Trials Search

Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Janssen
Indentifier #: NCT01830543
Title: An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention, PIONEER AF-PCI
Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Regado
Indentifier #: NCT01848106
Title: A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention. REG1-CLIN310